PHIO — Phio Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $9.37m
- $3.98m
Annual cashflow statement for Phio Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.79 | -13.3 | -11.5 | -10.8 | -7.15 |
| Depreciation | |||||
| Non-Cash Items | 0.136 | 0.247 | 0.414 | 0.429 | 0.141 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.327 | 0.99 | -1.26 | -0.536 | -0.138 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -8.8 | -11.9 | -12.1 | -10.7 | -7.11 |
| Capital Expenditures | -0.019 | -0.051 | -0.121 | -0.005 | -0.001 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.009 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.019 | -0.051 | -0.121 | -0.005 | 0.008 |
| Financing Cash Flow Items | -0.017 | -0.001 | -0.026 | -0.037 | -0.006 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.1 | 21.7 | -0.026 | 7.41 | 4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.31 | 9.81 | -12.3 | -3.34 | -3.11 |